Millennium Management’s HCW Biologics HCWB Stock Holding History

Millennium Management’s Portfolio HCWB Stock Details HCWB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-189	Closed	-$145K	–	7029
2021 Q3	$145K	Buy	+189	New	+$199K	﹤0.01%	6261

Other funds holding HCWB

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Millennium Management's HCWB Position: Q4 2021 in Review

Millennium Management sold out of HCW Biologics (HCWB) in Q4 2021, closing a stake of 189 shares — an estimated $145K sold.

Millennium Management first reported a position in HCWB in Q3 2021 and held it in 1 quarter. The position peaked at $145K in Q3 2021. 11 funds tracked by Wall St. Rank hold HCWB as of Q4 2021.

Millennium Management reported no remaining HCW Biologics position as of Q4 2021 after selling out during the quarter.
Millennium Management sold 189 HCW Biologics shares in Q4 2021, an estimated $145K.
Millennium Management first reported a position in HCW Biologics in Q3 2021 and held it in 1 quarter.
Millennium Management's HCW Biologics position peaked at $145K in Q3 2021.
11 funds tracked by Wall St. Rank held HCW Biologics as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.